The Pharmacist's Role in Improving Early Diagnosis for Patients with Chronic CoughPremiere Date: Wednesday, July 21, 2021
This activity offers CE credit for:%>
- Pharmacists (ACPE)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Thursday, July 21, 2022
Note: Credit Is No Longer Available
|Mandel R. Sher, MD (Moderator)
Founder, Sher Allergy Specialists
Founder, Center for Cough
Clinical Professor of Medicine and Pediatrics
Division of Allergy & Immunology
University of South Florida, Morsani College of Medicine, Johns Hopkins All Children's Hospital
St. Petersburg, FL
|Megan M. Adelman, PharmD, BCPS, BCGP, CDCES
Family Medicine Clinical Pharmacist
Cleveland Clinic Akron General Medical Center
Clinical Adjunct Professor
Family and Community Medicine
Northeast Ohio Medical University
Chronic cough, particularly those due to hypersensitivity, is under-recognized by health care professionals and leads to heavy patient and health system burden including costs and time associated with multiple provider visits, testing, and treatment as well as a decreased quality of life (QoL) due to patients experiencing depression, fatigue, stress incontinence, fear of social gatherings, and annoyance of the patients’ support systems. Pharmacists can facilitate patients on their journey to diagnosis by recognizing the clinical presentation of chronic cough and providing guidance to patients regarding the actions they can take to receive accurate diagnoses and treatment plans.
This CME Outfitters podcast will present a patient case that shows how pharmacists can talk to patients presenting with cough, including recommending cough products, discussions about cough hypersensitivity syndrome, and facilitating patients who may have chronic cough to the next steps.
At the end of this CE activity, participants should be able to:
- Recognize the clinical presentation of chronic cough.
- Provide guidance to patients about appropriate actions to take to receive an accurate diagnosis and treatment plan for chronic cough.
Supported by an educational grant from Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
CPE Credit (Pharmacists):
CME Outfitters, LLC, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. .5 contact hours (0.05 CEUs) Universal Activity Number: Enduring: 0376-0000-21-179-H01-P
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Sher reports that he receives research support from Bayer; Bellus Health Inc.; Merck & Co., Inc; and Shionogi Inc. He is a consultant for Bayer; Bellus Health Inc.; Merck & Co., Inc.; Shionogi Inc.; Nocion Therapeutics Inc; and NeRRe Therapeutics.
Dr. Adelman has no disclosures to report.
Julie Strickland, PharmD (planning committee) has no disclosures to report.
Evan Luberger (planning committee) has no disclosures to report.
Jan Perez (planning committee) has no disclosures to report.
Sharon Tordoff (planning committee) has no disclosures to report.
Disclosures were obtained from the CME Outfitters, LLC staff: No disclosures to report.
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).